Cardiol Therapeutics (CRDL) Raw Materials (2020 - 2022)

Cardiol Therapeutics has reported Raw Materials for 3 years, with the latest figure at $259966.1 in Q3 2022.

• For the quarter ending Q3 2022, Raw Materials fell 3.48% year-over-year to $259966.1; the trailing twelve-month figure through Sep 2022 stood at $259966.1 (down 3.48% YoY), and the FY2021 full-year result was $268981.4, up 3.43% from the prior year.
• Raw Materials for Q3 2022 stood at $259966.1, down from $265931.5 in the prior quarter.
• The five-year high for Raw Materials was $275827.2 in Q2 2021, with the low at $259966.1 in Q3 2022.
• Historically, Raw Materials has averaged $266827.8 across 3 years, with a median of $267672.4 in 2022.
• Annual changes were most pronounced in 2021 — Raw Materials increased 3.43% — and 2022, when it slipped 3.59%.
• Cardiol Therapeutics' Raw Materials stood at $260070.7 in 2020, then advanced by 3.43% to $268981.4 in 2021, then retreated by 3.35% to $259966.1 in 2022.
• The last three Raw Materials figures came in at $259966.1 (Q3 2022), $265931.5 (Q2 2022), and $267672.4 (Q1 2022), per Business Quant data.